Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FS KKR CAPITAL CORP.

(FSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

FS KKR Capital : Wells Fargo Adjusts Price Target on FS KKR Capital to $19 from $22, Keeps Underweight Rating

10/25/2021 | 10:25am EST


ę MT Newswires 2021
All news about FS KKR CAPITAL CORP.
01/19FS KKR CAPITAL : FSK Completes Offering of $500,000,000 3.250% Notes Due 2027 - Form 8-K
PU
01/19FS KKR CAPITAL CORP : Entry into a Material Definitive Agreement, Creation of a Direct Fin..
AQ
01/19FS KKR Capital Corp. Completes Offering of $500,000,000 3.250% Notes Due 2027
CI
01/18FSK Completes Offering of $500,000,000 3.250% Notes Due 2027
PR
01/13FS KKR CAPITAL CORP : Entry into a Material Definitive Agreement, Financial Statements and..
AQ
01/11Financial Stocks Climb Premarket Tuesday
MT
01/11FS KKR CAPITAL : FSK Prices Public Offering of $500,000,000 3.250% Notes Due 2027 - Form 8..
PU
01/11FS KKR CAPITAL CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-..
AQ
01/11FS KKR Capital Prices $500 Million Notes Offering
MT
01/10FSK Prices Public Offering of $500,000,000 3.250% Notes Due 2027
PR
More news
Analyst Recommendations on FS KKR CAPITAL CORP.
More recommendations
Financials (USD)
Sales 2021 1 054 M - -
Net income 2021 1 503 M - -
Net Debt 2021 8 405 M - -
P/E ratio 2021 3,07x
Yield 2021 11,5%
Capitalization 6 036 M 6 036 M -
EV / Sales 2021 13,7x
EV / Sales 2022 10,6x
Nbr of Employees -
Free-Float 99,8%
Chart FS KKR CAPITAL CORP.
Duration : Period :
FS KKR Capital Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FS KKR CAPITAL CORP.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 21,48 $
Average target price 22,63 $
Spread / Average Target 5,33%
EPS Revisions
Managers and Directors
Michael Craig Forman Chairman & Chief Executive Officer
Daniel Pietrzak Co-President & Chief Investment Officer
Brian Gerson Co-President
Enrico Salvatore Gaglioti Co-President
Steven C. Lilly Chief Financial Officer
Sector and Competitors